VasoDynamics Sets-up Laboratory at Stevenage Bioscience Catalyst Gallery VasoDynamics Sets-up Laboratory at Stevenage Bioscience Catalyst By Chloe Atkinson|2024-04-10T10:07:22+00:00March 28th, 2024|Uncategorized| Read More
NG11-2 Phase-Ib Dose Escalation Phase Completes & Dose Expansion Cohort Open to Enrolment Gallery NG11-2 Phase-Ib Dose Escalation Phase Completes & Dose Expansion Cohort Open to Enrolment By Chloe Atkinson|2024-03-12T13:58:56+00:00March 4th, 2024|Uncategorized| Read More
VasoDynamics initiates NG13 optimisation development with key appointment Gallery VasoDynamics initiates NG13 optimisation development with key appointment By Chloe Atkinson|2024-03-12T14:33:05+00:00February 8th, 2024|Uncategorized| Read More
Labour Shadow Health Team Visit Stevenage Bioscience Catalyst and Discuss VasoDynamics’ Technology Gallery Labour Shadow Health Team Visit Stevenage Bioscience Catalyst and Discuss VasoDynamics’ Technology By Bradley Shaw|2024-03-12T13:11:36+00:00February 7th, 2024|Uncategorized| Read More
NG11-2 Phase-Ib Dose Escalation Clinical Study Progresses to Final Dose Level Gallery NG11-2 Phase-Ib Dose Escalation Clinical Study Progresses to Final Dose Level By Chloe Atkinson|2023-12-21T13:06:37+00:00December 21st, 2023|Uncategorized| Read More
VasoDynamics files global patent (PCT) for the methods to select patients for the clinical studies on radiation-induced oral mucositis Gallery VasoDynamics files global patent (PCT) for the methods to select patients for the clinical studies on radiation-induced oral mucositis By Chloe Atkinson|2023-12-21T13:11:01+00:00November 7th, 2023|Uncategorized| Read More
NG11-2 Phase Ib Dose Escalation Clinical Study Progressing through Dose Levels Gallery NG11-2 Phase Ib Dose Escalation Clinical Study Progressing through Dose Levels By Chloe Atkinson|2023-10-19T09:17:29+00:00October 16th, 2023|Uncategorized| Read More
VasoDynamics strengthens management team with key appointments Gallery VasoDynamics strengthens management team with key appointments By Chloe Atkinson|2023-10-19T08:55:48+00:00August 1st, 2023|Uncategorized| Read More
First dose cohort completed and enrolment to second dose cohort commenced in NG11-2 Phase-Ib clinical trial Gallery First dose cohort completed and enrolment to second dose cohort commenced in NG11-2 Phase-Ib clinical trial By Chloe Atkinson|2023-08-10T14:06:33+00:00July 28th, 2023|Uncategorized| Read More
First patient dosed for the first week in NG11-2 Phase Ib clinical trial Gallery First patient dosed for the first week in NG11-2 Phase Ib clinical trial By Chloe Atkinson|2023-05-31T12:25:53+00:00May 26th, 2023|Uncategorized| Read More